AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,483 | -20.0% | 54 | 0.0% | 0.00% | – |
| Q2 2023 | $3,103 | +53.2% | 54 | 0.0% | 0.00% | – |
| Q1 2023 | $2,025 | +72.0% | 54 | +28.6% | 0.00% | – |
| Q4 2022 | $1,177 | -70.6% | 42 | -70.8% | 0.00% | -100.0% |
| Q3 2022 | $4,000 | +33.3% | 144 | +89.5% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 76 | -27.6% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | +100.0% | 105 | +38.2% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 76 | +81.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |